Impact of Mutational Status on Intracellular Effects of Cell-Permeable CaaX Peptides in Pancreatic Cancer Cells
- 1Department of Chemistry and Biochemistry, Institute of Biochemistry, University of Cologne, Zuelpicher Str. 47a, 50674, Cologne, Germany.
- 0Department of Chemistry and Biochemistry, Institute of Biochemistry, University of Cologne, Zuelpicher Str. 47a, 50674, Cologne, Germany.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cell-permeable CaaX-peptides interfere with protein prenylation, impacting KRas signaling differently in pancreatic cancer cells with wildtype versus mutated KRas. These peptides show promise for studying prenylated proteins.
Area Of Science
- Biochemistry
- Cell Biology
- Cancer Research
Background
- Prenyltransferases attach lipid groups to proteins via CaaX motifs, enabling membrane association crucial for signaling and trafficking.
- Posttranslational modification by prenylation is vital for protein function in cellular processes like signaling and apoptosis.
- Cell-permeable CaaX-peptides are emerging tools to modulate protein prenylation.
Purpose Of The Study
- To investigate the relevance of KRas mutational status in pancreatic cancer cells treated with CaaX-peptides.
- To compare the effects of CaaX-peptides on KRas wildtype (BxPC-3) and KRas mutated (PANC-1) pancreatic cancer cells.
- To elucidate the impact of CaaX-peptides on KRas localization and downstream signaling pathways.
Main Methods
- Comparative analysis of CaaX-peptide activity in KRas wildtype and mutated pancreatic cancer cell lines.
- Assessment of CaaX-peptide internalization in different cell lines.
- Evaluation of KRas plasma membrane localization and downstream signaling alterations.
Main Results
- CaaX-peptides differentially affect KRas wildtype and mutated pancreatic cancer cells despite similar internalization rates.
- Altered KRas plasma membrane localization was observed in PANC-1 cells, suggesting disturbed prenylation.
- CaaX-peptides influenced KRas signaling and KRas-dependent regulators like NF1 and SOS1, with effects dependent on KRas mutation status.
Conclusions
- CaaX-peptides exhibit differential effects on pancreatic cancer cells based on KRas mutational status.
- CaaX-peptides can disrupt KRas prenylation and alter its plasma membrane localization in KRas-mutated cells.
- CaaX peptides are valuable tools for studying prenylated proteins and hold therapeutic potential for cancer treatment.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

